5NG Stock Overview
Healthway Medical Corporation Limited, an investment holding company, provides healthcare management services primarily in Singapore. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Healthway Medical Corporation Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | S$0.047 |
52 Week High | S$0.05 |
52 Week Low | S$0.021 |
Beta | 0.60 |
11 Month Change | 0% |
3 Month Change | 2.17% |
1 Year Change | 23.68% |
33 Year Change | 46.88% |
5 Year Change | 30.56% |
Change since IPO | -79.11% |
Recent News & Updates
Recent updates
Shareholder Returns
5NG | SG Healthcare | SG Market | |
---|---|---|---|
7D | 0% | -0.2% | 0.9% |
1Y | 23.7% | -11.8% | 14.9% |
Return vs Industry: 5NG exceeded the SG Healthcare industry which returned -18% over the past year.
Return vs Market: 5NG exceeded the SG Market which returned -6.7% over the past year.
Price Volatility
5NG volatility | |
---|---|
5NG Average Weekly Movement | 15.1% |
Healthcare Industry Average Movement | 5.6% |
Market Average Movement | 4.6% |
10% most volatile stocks in SG Market | 14.7% |
10% least volatile stocks in SG Market | 2.2% |
Stable Share Price: 5NG's share price has been volatile over the past 3 months.
Volatility Over Time: 5NG's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of SG stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1990 | n/a | Stephens Lo | www.healthwaymedical.com |
Healthway Medical Corporation Limited, an investment holding company, provides healthcare management services primarily in Singapore. The company operates in two segments, Primary Healthcare and Specialist Healthcare. The Primary Healthcare segment offers services in family medicine, dentistry, and healthcare benefit management areas, as well as invests in strategic medical related business.
Healthway Medical Corporation Limited Fundamentals Summary
5NG fundamental statistics | |
---|---|
Market cap | S$213.17m |
Earnings (TTM) | S$8.69m |
Revenue (TTM) | S$160.85m |
24.5x
P/E Ratio1.3x
P/S RatioIs 5NG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
5NG income statement (TTM) | |
---|---|
Revenue | S$160.85m |
Cost of Revenue | S$124.84m |
Gross Profit | S$36.01m |
Other Expenses | S$27.32m |
Earnings | S$8.69m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.0019 |
Gross Margin | 22.39% |
Net Profit Margin | 5.40% |
Debt/Equity Ratio | 0.3% |
How did 5NG perform over the long term?
See historical performance and comparison